Literature DB >> 24568836

Prognostic factors in primary salivary gland mucoepidermoid carcinoma: an analysis of 376 cases in an Eastern Chinese population.

S Liu1, A Ow2, M Ruan3, W Yang1, C Zhang1, L Wang4, C Zhang1.   

Abstract

Mucoepidermoid carcinoma (MEC) is an infrequent malignant neoplasm that originates most commonly in the salivary glands. The present study aimed to provide new information on prognostic factors in patients with salivary gland MEC. A retrospective analysis of the medical records of patients diagnosed with primary salivary gland MEC between 2003 and 2010 was conducted. The incidence of MEC in the minor salivary glands (62.2%) was almost twice that in the major salivary glands (37.8%). The most frequently affected sites were the parotid gland and palate. Lymph node metastasis was reported more frequently in male than female patients (P = 0.02), in high-grade than low/intermediate grade lesions (P < 0.001), and in lesions involving the submandibular gland (P < 0.001). The disease-free survival (DFS) at 5 years was 80.47%, with rates of 98.0%, 86.5%, and 38.5% for low-, intermediate-, and high-grade tumours, respectively. Among various clinicopathological factors, the only independent prognostic factor was histological grade (P < 0.001). Primary tumour site and histological grade are two important factors affecting cervical lymph node metastasis. Histological grade is the only independent factor affecting survival beyond tumor lymph node metastasis (TNM) staging in salivary gland MEC. Further advances in therapy are needed to improve the outcomes for patients with high-grade lesions.
Copyright © 2014 International Association of Oral and Maxillofacial Surgeons. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  lymph node metastasis; mucoepidermoid carcinoma (MEC); prognosis; salivary glands; tumour grade

Mesh:

Year:  2014        PMID: 24568836     DOI: 10.1016/j.ijom.2014.01.008

Source DB:  PubMed          Journal:  Int J Oral Maxillofac Surg        ISSN: 0901-5027            Impact factor:   2.789


  10 in total

1.  Overall and cause-specific survival for mucoepidermoid carcinoma of the major salivary glands: Analysis of 2210 patients.

Authors:  Zachary C Taylor; Erin A Kaya; Jeffrey D Bunn; Zachary D Guss; Brian J Mitchell; Robert K Fairbanks; Wayne T Lamoreaux; Aaron E Wagner; Ben J Peressini; Christopher M Lee
Journal:  World J Clin Oncol       Date:  2020-12-24

2.  Mucoepidermoid Carcinoma of the Salivary Glands: Survival and Prognostic Factors.

Authors:  Guevara-Canales Janet-Ofelia; Morales-Vadillo Rafael; Guzmán-Arias Guillermo; Cava-Vergiú Carlos-Enrique; Robello-Malatto José-Martín; Guerra-Miller Henry; Montes-Gil Jaime-Enrique
Journal:  J Maxillofac Oral Surg       Date:  2016-07-29

3.  Myoepithelial Carcinoma of the Nasopharynx: Report of a Rare Case and a Review of the Literature.

Authors:  Gwyneth Soon; Fredrik Petersson
Journal:  Head Neck Pathol       Date:  2015-06-27

4.  Management and outcome of parotid mucoepidermoid carcinoma by histological grade: A 21-year review.

Authors:  Masataka Taniuchi; Ryo Kawata; Tetsuya Terada; Masaaki Higashino; Hiromi Nishimura; Yoshitaka Kurisu; Hiroko Kuwabara; Yoshinobu Hirose
Journal:  Laryngoscope Investig Otolaryngol       Date:  2022-05-21

Review 5.  Management of salivary gland carcinomas - a review.

Authors:  Xiaoli Wang; Yijun Luo; Minghuan Li; Hongjiang Yan; Mingping Sun; Tingyong Fan
Journal:  Oncotarget       Date:  2017-01-17

6.  Prognostic factors of palatal mucoepidermoid carcinoma: a retrospective analysis based on a double-center study.

Authors:  Wenguang Xu; Yufeng Wang; Xiaofeng Qi; Junqi Xie; Zheng Wei; Xiteng Yin; Zhiyong Wang; Jian Meng; Wei Han
Journal:  Sci Rep       Date:  2017-03-06       Impact factor: 4.379

7.  Nomogram to predict the prognosis of parotid gland mucoepidermoid carcinoma: a population-based study of 1306 cases.

Authors:  Jian Sun; Yang Sun; Fei Yang; Qianrong Zhou; Wenjuan Liu; Yong Cheng; Xingwen Wu; Tinglan Chen; Ruixue Li; Borui Huang; Wael Att; Youcheng Yu; Wei Bi
Journal:  PeerJ       Date:  2019-07-01       Impact factor: 2.984

8.  Anti-tumor effect of inhibition of IL-6 signaling in mucoepidermoid carcinoma.

Authors:  Daiki Mochizuki; April Adams; Kristy A Warner; Zhaocheng Zhang; Alexander T Pearson; Kiyoshi Misawa; Scott A McLean; Gregory T Wolf; Jacques E Nör
Journal:  Oncotarget       Date:  2015-09-08

9.  Mandibular central mucoepidermoid carcinoma: a case report and review of the literature.

Authors:  Ilson Sepúlveda; Michael Frelinghuysen; Enrique Platin; M Loreto Spencer; Alvaro Compan; Juan Munzenmayer; David Ulloa
Journal:  Case Rep Oncol       Date:  2014-10-30

10.  Clinicopathological features and outcomes of major salivary gland mucoepidermoid carcinoma: do they vary in different age groups.

Authors:  Yujiao Li; Chaosu Hu
Journal:  Transl Cancer Res       Date:  2020-11       Impact factor: 1.241

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.